Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clindamycin palmitate hydrochloride
Drug ID BADD_D00485
Description Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657] Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]
Indications and Usage For the treatment of serious infections caused by susceptible anaerobic bacteria, including Bacteroides spp., Peptostreptococcus, anaerobic streptococci, Clostridium spp., and microaerophilic streptococci. May be useful in polymicrobic infections such as intra-abdominal or pelvic infections, osteomyelitis, diabetic foot ulcers, aspiration pneumonia and dental infections. May also be used to treat MSSA and respiratory infections caused by S. pneumoniae and S. pyogenes in patients who are intolerant to other indicated antibiotics or who are infected with resistant organism. May be used vaginally to treat vaginosis caused by Gardnerella vaginosa. Clindamycin reduces the toxin producing effects of S. aureus and S. pyogenes and as such, may be particularly useful for treating necrotizing fasciitis. May be used topically to treat acne.
Marketing Status Prescription; Discontinued
ATC Code D10AF01; G01AA10; J01FF01
DrugBank ID DB01190
KEGG ID D01990
MeSH ID C000489
PubChem ID 16052038
TTD Drug ID Not Available
NDC Product Code 65162-468; 0009-0760; 11014-0124; 0574-0129; 68108-0507; 59762-0016; 67321-303; 67787-515; 65862-545; 65015-759; 64980-511; 63629-2523; 23155-603; 67321-304; 63629-2391
Synonyms clindamycin palmitate | 7-chloro-7-deoxylincomycin palmitate | Cleocin palmitate | clindamycin palmitate hydrochloride | 7-chlorolincomycin palmitate
Chemical Information
Molecular Formula C34H64Cl2N2O6S
CAS Registry Number 25507-04-4
SMILES CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Azotaemia20.01.01.001--Not Available
Dermatitis bullous23.03.01.002--
Dermatitis exfoliative10.01.01.004; 23.03.07.001--
Diarrhoea07.02.01.001--
Eosinophilia01.02.04.001--
Erythema multiforme23.03.01.003; 10.01.03.015--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Leukopenia01.02.02.001--Not Available
Liver function test abnormal13.03.01.013--Not Available
Nausea07.01.07.001--
Neutropenia01.02.03.004--Not Available
Oesophagitis07.08.05.001--
Oliguria20.01.03.004--Not Available
Polyarthritis15.01.01.005--Not Available
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Rash23.03.13.001--Not Available
Stevens-Johnson syndrome12.03.01.014; 23.03.01.007; 11.07.01.005; 10.01.03.020--
Thrombocytopenia01.08.01.002--Not Available
Urticaria10.01.06.001; 23.04.02.001--
Vaginal infection21.14.02.002; 11.01.10.002--
Vomiting07.01.07.003--
The 1th Page    1    Total 1 Pages